Patents by Inventor Michael Gordon Campbell

Michael Gordon Campbell has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11963959
    Abstract: Inhibitors against SARS-COV-1, SARS-CoV-2 (Covid-19), MERS-CoV, and variants within each, including methods of treating a subject suffering from such respiratory disease.
    Type: Grant
    Filed: August 12, 2022
    Date of Patent: April 23, 2024
    Assignees: Southwest Research Institute, The Government of the United States, as represented by The Secretary of the Army, The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.
    Inventors: Jonathan A. Bohmann, Nadean M. Gutierrez, Joseph A. Mcdonough, Robert Francis Campbell, Michael Gordon Joyce, Rekha Panchal, Rajeshwer Sankhala, Allen Duplantier
  • Patent number: 7501446
    Abstract: The present invention is directed to compounds useful in the treatment of diseases associated with prenylation of proteins and pharmaceutically acceptable salts thereof, to pharmaceutical compositions comprising same, and to methods for inhibiting protein prenylation in an organism using the same.
    Type: Grant
    Filed: January 1, 2007
    Date of Patent: March 10, 2009
    Assignee: PPD Discovery, Inc.
    Inventors: Francine Feirong Li, Kenneth S. Rehder, Michael Gordon Campbell, Celeste Patrice Viscardi, Jon-Paul Strachan, Zhengming Guo
  • Patent number: 7166619
    Abstract: The present invention is directed to compounds useful in the treatment of diseases associated with prenylation of proteins and pharmaceutically acceptable salts thereof, to pharmaceutical compositions comprising same, and to methods for inhibiting protein prenylation in an organism using the same.
    Type: Grant
    Filed: August 6, 2003
    Date of Patent: January 23, 2007
    Assignee: PPD Discovery , Inc.
    Inventors: Francine Feirong Li, Kenneth S. Rehder, Michael Gordon Campbell, Celeste Patrice Viscardi, Jon-Paul Strachan, Zhengming Guo
  • Publication number: 20040116425
    Abstract: The present invention is directed to compounds useful in the treatment of diseases associated with prenylation of proteins and pharmaceutically acceptable salts thereof, to pharmaceutical compositions comprising same, and to methods for inhibiting protein prenylation in an organism using the same.
    Type: Application
    Filed: August 6, 2003
    Publication date: June 17, 2004
    Inventors: Francine Feirong Li, Kenneth S. Rehder, Michael Gordon Campbell, Celeste Patrice Viscardi, Jon-Paul Strachan, Zhengming Guo